On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Endothelium - one of the largest tissues in body
- Endothelium is an active tissue
- Endothelial cells (EC) heterogeneity (1)
- Endothelial cells (EC) heterogeneity (2)
- Endothelial cells activity
- Vasoregulation
- EC and coagulation
- Regulatory mechanisms - anti and procoagulant
- EC and fibrinolysis
- The leukocyte adhesion cascade
- EC and inflammation/innate immunity
- Triggering of the cell mediated immune responses
- Role of the endothelium in autoimmune diseases
- Endothelium and autoimmunity
- EC and immune responses
- Endothelium as a target
- EC as target: anti-EC antibodies (AECA)
- AutoAbs against ECs (AECA)
- Endothelial planted antigens recognized by AECA
- AECA and pro-inflammatory/coagulant phenotype
- AECA may induce an endothelial lysis
- AECA may induce an endothelial apoptosis
- EC as target: ANCA
- ANCA-associated vasculitis
- EC as target: systemic vasculitis
- Giant cell arteritis
- EC as target: immunocomplexes
- Immune complex-mediated vasculitis
- Endothelium in autoimmune atherosclerosis
- Atherosclerosis: response to injury hypothesis
- EC as target: atherosclerosis
- EC as player: atherosclerosis
- EC activation in autoimmune diseases
- Vasculopathy vs. vasculitis
- Endothelium and antiphospholipid syndrome (APS)
- Endothelium as a target for antiphospholipid (aPL)
- Activated ECs as players in APS
- APS: pathogenic mechanisms
- Possible receptors for bGlycoprotein I (bGPI)
- Endothelium and scleroderma (SSc)
- Role of vascular damage in SSc pathogenesis
- Markers of EC perturbation
- Circulating markers: von Willebrand factor
- Circulating markers: endothelin-1
- Circulating markers: TPA and PAI-1
- Circulating markers: soluble adhesion molecules
- Circulating markers: sTM
- Circulating ECs (CEC)
- Increased occurrence of CECs
- Brachial FMD (omeral artery)
Topics Covered
- Physiological functions of the endothelium
- Endothelium as a target and player of immune responses
- Endothelium in autoimmune vasculitis and vasculopathies
- Anti-endothelial cell antibodies
- Anti-phospholipid syndrome
- Scleroderma
- Markers of endothelial perturbation
Talk Citation
Meroni, P.L. (2007, October 1). Endothelium and autoimmunity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/MAZW2886.Export Citation (RIS)
Publication History
- Published on October 1, 2007
Financial Disclosures
- Prof. Pier Luigi Meroni has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.